BIIB
Stock·CLOSEDNYSE/NASDAQBiogen: Biotechnology company focused on neurological and neurodegenerative diseases.
Price
218.39
24H
—
Volume 24h
$1.11M
OI (USD)
$1.08M
Market Cap
$32.04B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | BIIBUSDT | 218.58 | 217.07 | +69.6 bps | --:--:--+0.1981%(+216.93% ann) | $1.02M | 92.6% | $29.82K | 45d |
 | BIIBSTOCK_USDT | 216.08 | 215.94 | +6.5 bps | --:--:--+0.0200%(+21.90% ann) | $82.04K | 7.4% | $1.05M | 44d |
 | BIIB_USDT | 217.36 | 217.36 | +0.0 bps | --:--:--+0.0000%(+0.00% ann) | $247 | 0.0% | $1.2K | 37d |